CSF2 and familial pancreatic carcinoma: GVAX is one of the first tested vaccines against pancreatic cancer, and it is composed of the irradiated tumor cell-expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) (Le et al., 2015; Yarchoan et al., 2020).